Outcome of patients treated with engager transapical aortic valve implantation: One-Year results of the feasibility study

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

Volumn 8, Issue 5, 2013, Pages 332-336

  Sündermann, Simon H ^a   Grünenfelder, Jürg ^a   Corti, Roberto ^b   Rastan, Ardawan J ^c   Linke, Axel ^d   Lange, Rüdiger ^e   Falk, Volkmar ^a   Bleiziffer, Sabine ^e  

^a Division of Cardiovascular Surgery   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Department of Cardiac Surgery ^*  (Switzerland)

^d UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aortic valve disease; Minimally invasive surgery; Transapical aortic valve replacement

Indexed keywords

AGED; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLETE HEART BLOCK; DEATH; DIALYSIS; ECHOCARDIOGRAPHY; ENGAGER TRANSAPICAL AORTIC VALVE IMPLANTATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; IMPLANTED HEART PACEMAKER; INTESTINE ISCHEMIA; KIDNEY FAILURE; MALE; MEDICAL DEVICE COMPLICATION; MULTIPLE ORGAN FAILURE; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PARAVALVULAR AORTIC REGURGITATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY FAILURE; TRACHEA DISEASE; TRACHEAL PERFORATION; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; TRANSVALVULAR AORTIC REGURGITATION; TREATMENT DURATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; FEASIBILITY STUDIES; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; TREATMENT OUTCOME;

EID: 84891704504     PISSN: 15569845     EISSN: 15590879     Source Type: Journal    
DOI: 10.1097/IMI.0000000000000018     Document Type: Article

References (18)

1. Thomas M, Schymik G,Walther T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2011;124:425-433.
2. Kempfert J, Rastan AJ, Beyersdorf F, et al. Trans-apical aortic valve implantation using a newself-expandable bioprosthesis: initial outcomes. Eur J Cardiothorac Surg. 2011;40:1114-1119.
3. Treede H, Mohr FW, Baldus S, et al. Transapical transcatheter aortic valve implantation using the JenaValve system: acute and 30-day results of the multicentre CE-mark study. Eur J Cardiothorac Surg. 2012;41: e131-e138.
4. Falk V, Walther T, Schwammenthal E, et al. Transapical aortic valve implantation with a self-expanding anatomically oriented valve. Eur Heart J. 2011;32:878-887.
5. Sündermann SH, Grünenfelder J, Corti R, et al. Feasibility of the Engager aortic transcatheter valve system using a flexible over-the-wire design. Eur J Cardiothorac Surg. 2012;42:e48-e52.
6. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32:205-217.
7. Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55: 1080-1090.
8. Clavel MA, Dumont E, Pibarot P, et al. Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation. Ann Thorac Surg. 2009;87:618-621.
9. Kapadia SR, Svensson L, Tuzcu EM. Successful percutaneous management of left main trunk occlusion during percutaneous aortic valve replacement. Catheter Cardiovasc Interv. 2009;73:966-972.
10. Bagur R, Rodés-Cabau J, Gurvitch R, et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv. 2012;5:540-551.
11. Abdel-Wahab M, Zahn R, Horack M, et al., for the German transcatheter aortic valve interventions registry investigators. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart. 2011;97:899-906.
12. Kodali SK, Williams MR, Smith CR, et al., for the PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-1695.
13. Wendler O,Walther T, Nataf P, et al. Trans-apical aortic valve implantation: univariate and multivariate analyses of the early results from the SOURCE registry. Eur J Cardiothorac Surg. 2010;38:119-127.
14. Walther T, Falk V, Kempfert J, et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg. 2008; 33:983-988.
15. Ewe SH, Delgado V, Ng AC, et al. Outcomes after transcatheter aortic valve implantation: transfemoral versus transapical approach. Ann Thorac Surg. 2011;92:1244-1251.
16. Buellesfeld L, Gerckens U, Schuler G, et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol. 2011;57:1650-1657.
17. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation. 2009; 119:3009-3016.
18. Kempfert J, Treede H, Rastan AJ, et al. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA): 6-month outcomes. Eur J Cardiothorac Surg. 2013;43:52-56.